DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells

References

• Bukh I, Calcedo R, Roy S, Carnathan DG, Grant R, Ratcliffe SJ, et al. Increased mucosal CD4+ T cell activation following vaccination with an adenovirus vector in rhesus macaques. 29th Annual Nonhuman Primate Models for AIDS Symposium. Seattle, WA, 2011:Conference Presentation.
   Google Scholar
• Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, et al. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. J Virol 2012; 86:2239 - 50; http://dx.doi.org/10.1128/JVI.06175-11; PMID: 22156519
   PubMed Web of Science ®Google Scholar
• Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061 - 8; http://dx.doi.org/10.1038/ni845; PMID: 12368910
   PubMed Web of Science ®Google Scholar
• Hess C, Altfeld M, Thomas SY, Addo MM, Rosenberg ES, Allen TM, et al. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet 2004; 363:863 - 6; http://dx.doi.org/10.1016/S0140-6736(04)15735-8; PMID: 15031033
   PubMed Web of Science ®Google Scholar
• Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781 - 9; http://dx.doi.org/10.1182/blood-2005-12-4818; PMID: 16467198
   PubMed Web of Science ®Google Scholar
• Hersperger AR, Migueles SA, Betts MR, Connors M. Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control. Curr Opin HIV AIDS 2011; 6:169 - 73; http://dx.doi.org/10.1097/COH.0b013e3283454c39; PMID: 21399496
   PubMed Web of Science ®Google Scholar
• Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al, Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881 - 93; http://dx.doi.org/10.1016/S0140-6736(08)61591-3; PMID: 19012954
   PubMed Web of Science ®Google Scholar
• McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, et al, Step Study Protocol Team. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008; 372:1894 - 905; http://dx.doi.org/10.1016/S0140-6736(08)61592-5; PMID: 19012957
   PubMed Web of Science ®Google Scholar
• Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286:1353 - 7; http://dx.doi.org/10.1126/science.286.5443.1353; PMID: 10558989
   PubMed Web of Science ®Google Scholar
• Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104:942 - 7; http://dx.doi.org/10.1182/blood-2003-09-3333; PMID: 15117761
   PubMed Web of Science ®Google Scholar
• Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17:1881 - 8; http://dx.doi.org/10.1097/00002030-200309050-00006; PMID: 12960820
   PubMed Web of Science ®Google Scholar
• Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008; 22:439 - 46; http://dx.doi.org/10.1097/QAD.0b013e3282f2dbe7; PMID: 18301056
   PubMed Web of Science ®Google Scholar
• Hutnick NA, Carnathan DG, Dubey SA, Cox KS, Kierstead L, Makadonas G, et al. Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. PLoS ONE 2010; 5:e14385; http://dx.doi.org/10.1371/journal.pone.0014385; PMID: 21203546
   PubMed Web of Science ®Google Scholar
• Hutnick NA, Carnathan DG, Dubey SA, Makedonas G, Cox KS, Kierstead L, et al. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. Nat Med 2009; 15:876 - 8; http://dx.doi.org/10.1038/nm.1989; PMID: 19620962
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, et al. Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nat Med 2009; 15:873 - 5; http://dx.doi.org/10.1038/nm.1991; PMID: 19620961
   PubMed Web of Science ®Google Scholar
• Benlahrech A, Harris J, Meiser A, Papagatsias T, Hornig J, Hayes P, et al. Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc Natl Acad Sci USA 2009; 106:19940 - 5; PMID: 19918060
   PubMed Web of Science ®Google Scholar
• Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, et al. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci USA 2007; 104:18648 - 53; http://dx.doi.org/10.1073/pnas.0709198104; PMID: 18000037
   PubMed Web of Science ®Google Scholar
• Chattergoon MA, Saulino V, Shames JP, Stein J, Montaner LJ, Weiner DB. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 2004; 22:1744 - 50; http://dx.doi.org/10.1016/j.vaccine.2004.01.036; PMID: 15068858
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 2005; 175:112 - 23; PMID: 15972637
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. Developing DNA vaccines that call to dendritic cells. J Clin Invest 2004; 114:1241 - 4; PMID: 15520855
   PubMed Web of Science ®Google Scholar
• McKay PF, Barouch DH, Santra S, Sumida SM, Jackson SS, Gorgone DA, et al. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses. Eur J Immunol 2004; 34:1011 - 20; http://dx.doi.org/10.1002/eji.200324840; PMID: 15048711
   PubMed Web of Science ®Google Scholar
• Marsal J, Svensson M, Ericsson A, Iranpour AH, Carramolino L, Márquez G, et al. Involvement of CCL25 (TECK) in the generation of the murine small-intestinal CD8alpha alpha+CD3+ intraepithelial lymphocyte compartment. Eur J Immunol 2002; 32:3488 - 97; http://dx.doi.org/10.1002/1521-4141(200212)32:12<3488::AID-IMMU3488>3.0.CO;2-E; PMID: 12442331
   PubMed Web of Science ®Google Scholar
• Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, Mack M, et al. Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. Blood 2006; 107:3447 - 54; http://dx.doi.org/10.1182/blood-2005-07-2860; PMID: 16391017
   PubMed Web of Science ®Google Scholar
• Svensson M, Johansson-Lindbom B, Wurbel MA, Malissen B, Márquez G, Agace W. Selective generation of gut-tropic T cells in gut-associated lymphoid tissues: requirement for GALT dendritic cells and adjuvant. Ann N Y Acad Sci 2004; 1029:405 - 7; http://dx.doi.org/10.1196/annals.1309.025; PMID: 15681793
   PubMed Web of Science ®Google Scholar